Periodontal manifestations of systemic disease and management of patients with systemic disease.
Many studies show a strong association between diabetes mellitus and risk for periodontal disease destruction. Patients with non-insulin-dependent diabetes mellitus have an increased risk of developing destructive periodontal disease. Under similar plaque conditions, adult patients with long-term, poorly controlled diabetes mellitus have more attachment and bone loss than controlled diabetic patients. Most patients with diabetes mellitus respond to conventional periodontal treatment, but in some cases the response may be related to the degree of metabolic control. Periodontal treatment may have a beneficial effect on the metabolic status of poorly controlled diabetes. Tetracycline therapy may be an effective adjunctive treatment in the management of periodontal disease in diabetic patients by blocking collagenase-dependent periodontal tissue destruction. Pyostomatitis vegetans is frequently associated with chronic inflammatory bowel disease and is a marker for the disease. Plaque control with chlorhexidine gluconate should be preceded by mechanical removal of plaque and calculus in patients with leukemia undergoing chemotherapy. A distinct gingival lesion is associated with Wegener's granulomatosis, a potentially fatal disease that, if detected early, has a favorable prognosis.
Mendieta
C
C
Universidad de Barcelona, Spain.
Reeve
C M
CM
D000293:Adolescent; D002648:Child; D017742:Dental Care for Chronically Ill; D048909:Diabetes Complications; D014890:Granulomatosis with Polyangiitis / Q000150:complications; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications; D007938:Leukemia / Q000150:complications; D009503:Neutropenia / Q000150:complications; D010214:Papillon-Lefevre Disease / Q000150:complications; D010510:Periodontal Diseases / Q000209:etiology* / Q000628:therapy